Cerebrolysin

Cerebrolysin (CBL60) is a standardized neurotrophic peptide preparation derived from porcine brain tissue via enzymatic hydrolysis. It is composed of approximately 25% low-molecular-weight peptides (<10 kDa) and 75% free amino acids, including aspartic acid, glutamic acid, serine, histidine, glycine, alanine, valine, leucine, lysine, and proline. As a complex neuropeptide mixture, it mimics endogenous neurotrophic factors such as BDNF, NGF, GDNF, and CNTF, exerting multimodal neuroprotective and neurorestorative effects. It penetrates the blood–brain barrier, promotes neuronal survival and differentiation, enhances synaptic plasticity, inhibits neuronal apoptosis and oxidative stress, and improves cerebral energy metabolism. Widely used in preclinical research and approved for clinical use in over 50 countries, it is indicated for stroke, traumatic brain injury (TBI), Alzheimer’s disease, vascular dementia, and cognitive impairment. This product is supplied as high-purity lyophilized powder for biomedical research use only.